Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
By W. Tang, Zeneng Wang, B. Levison, Robert A. Koeth, Earl B. Britt, Xiaoming Fu, Yuping Wu, S. Hazen. New England Journal of Medicine, 2013
2,972 citations recorded by the source corpus.
BACKGROUND Recent studies in animals have shown a mechanistic link between intestinal microbial metabolism of the choline moiety in dietary phosphatidylcholine (lecithin) and coronary artery disease through the production of a proatherosclerotic metabolite, trimethylamine-N-oxide (TMAO). We investigated the relationship among intestinal microbiota-dependent metabolism of dietary phosphatidylcholine, TMAO levels, and adverse cardiovascular events in humans. METHODS We quantified plasma and urinary levels of TMAO and plasma choline and betaine levels by means of liquid chromatography and online tandem mass spectrometry after a phosphatidylcholine challenge (ingestion of two hard-boiled eggs and deuterium [d9]-labeled phosphatidylcholine) in healthy participants before and after the suppression of intestinal microbiota with oral broad-spectrum antibiotics. We further examined the relationship between fasting plasma levels of TMAO and incident major adverse cardiovascular events (death, myocardial infarction, or stroke) during 3 years of follow-up in 4007 patients undergoing elective coronary angiography. RESULTS Time-dependent increases in levels of both TMAO and its d9 isotopologue, as well as other choline metabolites, were detected after the phosphatidylcholine challenge. Plasma levels of TMAO were markedly suppressed after the administration of antibiotics and then reappeared after withdrawal of antibiotics. Increased plasma levels of TMAO were associated with an increased risk of a major adverse cardiovascular event (hazard ratio for highest vs. lowest TMAO quartile, 2.54; 95% confidence interval, 1.96 to 3.28; P<0.001). An elevated TMAO level predicted an increased risk of major adverse cardiovascular events after adjustment for traditional risk factors (P<0.001), as well as in lower-risk subgroups. CONCLUSIONS The production of TMAO from dietary phosphatidylcholine is dependent on metabolism by the intestinal microbiota. Increased TMAO levels are associated with an increased risk of incident major adverse cardiovascular events. (Funded by the National Institutes of Health and others.)
Subfields: Molecular Biology, Neurology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/53ec1b9c914297f2a8e067b2718503120d92ec2a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Curtis Huttenhower
- Nicola Segata
- Eric A. Franzosa
- F. Bäckhed
- F. Asnicar
- George Weingart
- Eric G. Pamer
- Dirk Gevers
In Neurology
In Rheumatology
Citations in the corpus
- Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk (2016, positive): “Human studies The association between TMAO levels and incident thrombotic event risk was examined in the Genebank Study (Tang et al., 2013).”
- Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. (2016, background): “Also in humans, PC or LC administration augmented TMA plasma levels and increased the risk for cardiovascular disease; notably, antibiotic treatment dramatically reduced TMA levels in these subjects [68,70].”
- 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association (2021, background): “45,67,68 The term “processed meats” includes meat, poultry, or seafood products preserved by smoking, curing, or salt-ing or the addition of chemical preservatives.”
- Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018, positive): “Recently, it has been shown that gut microbial production of trimethylamine N-oxide (TMAO) from dietary choline and l-carnitine increases the risk of developing cardiovascular disease in both mice and humans, independently of traditional cardiometabolic risk factors (89).”
- Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016, background): “factor for cardiovascular disease.(17,18,34) Bacterial DNA from the gut microbiota has been detected in human atherosclerotic plaques.”